• 1  Ruiz‐Irastorza G, Crowther M, Branch W, Khamashta MA. Antiphospholipid syndrome. Lancet 2010;376:1498–509. Cross Ref link Pubmed link
  • 2  Biggioggero M, Meroni PL. The geoepidemiology of the antiphospholipid antibody syndrome Autoimmun Rev 2010;9:299–304. Cross Ref link
  • 3  Bushnell CD, Goldstein LB. Diagnostic testing for coagulopathies in patients with ischemic stroke. Stroke 2000;31:3067–78. Cross Ref link Pubmed link
  • 4  Mok CC, Tang S, To C, Petri M. Incidence and risk factors of in systemic lupus erythematosus: a comparison of three ethnic groups. Arthritis Rheum 2005;52:2774–82. Cross Ref link Pubmed link
  • 5  Ruiz‐Irastorza G, Egurbide MV, Ugalde J, Aguirre C. High impact of antiphospholipid syndrome on irreversible organ damage and survival of patients with systemic lupus erythematosus. Arch Intern Med 2004;164:77–82. Cross Ref link Pubmed link
  • 6  Tektonidou MG, Laskari K, Panagiotakos DB, Moutsopoulos HM. Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies. Arthritis Rheum 2009;61:29–36. Cross Ref link Pubmed link
  • 7  Roldan V, Lecumberri R, Munoz‐Torrero JFS, et al. Thrombophilia testing in patients with venous thromboembolism. Findings from the RIETE registry. Thromb Res 2009;124:174–7. Cross Ref link Pubmed link
  • 8  Rai RS, Regan L, Clifford K, et al. Antiphospholipid antibodies and s2‐glycoprotein‐I in 500 women with recurrent miscarriage: results of a comprehensive screening approach. Hum Reprod 1995;10:2001–5. Pubmed link
  • 9  Font J, Lopez‐Soto A, Cervera R, et al. The ‘primary’ antiphospholipid syndrome: antiphospholipid antibody pattern and clinical features of a series of 23 patients. Autoimmunity 1991;9:69–75. Cross Ref link Pubmed link
  • 10  Uthman I, Khamashta M. Ethnic and geographical variation in antiphospholipid (Hughes) syndrome. Ann Rheum Dis 2005;64:1671–6. Cross Ref link Pubmed link
  • 11  Branch DW, Rodgers GM. Induction of endothelial cell tissue factor activity by sera from patients with antiphospholipid syndrome: a possible mechanism of thrombosis. Am J Obstet Gynecol 1993;168:206–10. Cross Ref link Pubmed link
  • 12  Amengual O, Atsumi T, Khamashta M, Hughes G. The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome. Thromb Haemost 1998;79:276–81. Pubmed link
  • 13  Malia RG, Kitchen S, Greaves M, et al. Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies. Br J Haematol 1990;76:101–7. Cross Ref link Pubmed link
  • 14  Atsumi T, Khamashta M., Amengual O, et al. Binding of anticardiolipin antibodies to protein C via beta2‐glycoprotein I (beta2‐GPI): a possible mechanism in the inhibitory effect of antiphospholipid antibodies on the protein C system. Clin Exp Immunol 1998;112:325–33. Cross Ref link Pubmed link
  • 15  de Laat B, Wu XX, van Lummel M, et al. Correlation between antiphospholipid antibodies that recognize domain I of beta2‐glycoprotein I and a reduction in the anticoagulant activity of annexin A5. Blood 2007;109:1490–4. Cross Ref link Pubmed link
  • 16  McNeil HP, Simpson RJ, Chesterman CN, et al. Anti‐phospholipid antibodies are directed against a complex antigen that includes a lipid‐binding inhibitor of coagulation: beta 2‐glycoprotein I (apolipoprotein H). Proc Nat Acad Sci 1990;87:4120–4. Cross Ref link Pubmed link
  • 17  Hudson N, Busque L, Rauch J, et al. Familial antiphospholipid syndrome and HLA‐DRB gene associations. Arthritis Rheum 1997;40:1907–8. Cross Ref link Pubmed link
  • 18  Lee YH, Choi SJ, Ji JD, et al. Association between the valine/leucine247 polymorphism of β2‐glycoprotein I and susceptibility to anti‐phospholipid syndrome: a meta‐analysis. Lupus 2012;21:865–71. Cross Ref link Pubmed link
  • 19  Sacre K, Brihaye B, Hyafil F, et al. Asymptomatic myocardial ischemic disease in antiphospholipid syndrome: a controlled cardiac magnetic resonance imaging study. Arthritis Rheum 2010;62:2093–100. Cross Ref link Pubmed link
  • 20  Asherson RA, Cervera R. Unusual manifestations of the antiphospholipid syndrome. Clin Rev Allergy Immunol 2003;25:61–78. Cross Ref link Pubmed link
  • 21  Erkan D, Yazici Y, Sobel R, et al. Primary antiphospholipid syndrome: functional outcome after 10 years. J Rheumatol 2000;12:2817–21.
  • 22  Sciascia S, Sanna G, Khamashta MA, et al. The estimated frequency of antiphospholipid antibodies in young adults with cerebrovascular events: a systematic review. Ann Rheum Dis 2014; in press. Pubmed link
  • 23  Erkan D, Aguiar CL, Andrade D, et al. 14th International Congress on Antiphospholipid Antibodies: task force report on antiphospholipid syndrome treatment trends. Autoimmun Rev 2014;13:685–96. Cross Ref link Pubmed link